NovaBridge Biosciences (NBP) Financial Statements
Free cash flow over the same period: -$20.6M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
NBPNovaBridge BiosciencesFollow NBP — free
—
Price chart with a free account
- Market cap
- 365.5M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Apr, in 163 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.3 | 236.4 | 13.8 | 0.6 | — | — | — | |
| Gross profit | — | — | 6.5 | — | — | — | — | |
| Research & development | 120.7 | 150.9 | 190.3 | 21.4 | 21.8 | 62.9 | — | |
| Operating income | — | — | — | -72.0 | -51.4 | -94.3 | -122.6 | |
| Pre-tax income | -208.6 | 74.0 | -366.4 | -82.2 | -49.7 | -88.3 | -117.6 | |
| Income tax | — | 1.9 | -0.5 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Net income | -208.6 | 72.2 | -365.9 | -207.7 | -22.2 | -46.3 | -75.5 | |
| Diluted EPS ($) | -28.90 | 0.46 | -2.09 | -1.09 | -0.12 | -0.21 | -0.30 | |
| Diluted shares (mn) | 7.4 | 157.2 | 174.7 | 191.4 | 186.7 | 220.3 | — |
USD millions · SEC XBRL
NovaBridge Biosciences — questions
- What is NovaBridge Biosciences's net income?
- -$75.5M over the twelve months to 2026-06-30.
- What is NovaBridge Biosciences's free cash flow?
- -$20.6M over the twelve months to 2026-06-30.
- What are NovaBridge Biosciences's diluted earnings per share?
- $-0.30 over the twelve months to 2026-06-30.
Every figure on this page comes from NovaBridge Biosciences's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.